Department of Health and Human Services April 1, 2005 – Federal Register Recent Federal Regulation Documents

Federal Allotments to State Developmental Disabilities Councils and Protection and Advocacy Formula Grant Programs for Fiscal Year 2006
Document Number: 05-6483
Type: Notice
Date: 2005-04-01
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
This notice sets forth Fiscal Year (FY) 2006 individual allotments and percentages of the total appropriation to States administering the State Developmental Disabilities Councils and Protection and Advocacy programs, pursuant to Section 122 and Section 142 of the Developmental Disabilities Assistance and Bill of Rights Act (Act). The allotment amounts are based on the FY 2006 President's Budget request and are contingent on congressional appropriations for FY 2006. If the Congress enacts a different appropriation amount in FY 2006, these allotments will be adjusted accordingly. The State allotments are available on the ADD homepage on the Internet: https:// www.acf.hhs.gov/programs/add/.
International Conference on Harmonisation; Guidance on E2E Pharmacovigilance Planning; Availability
Document Number: 05-6472
Type: Notice
Date: 2005-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ``E2E Pharmacovigilance Planning.'' The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance describes a method for summarizing the important potential and identified risks of a drug. It proposes a structure for a pharmacovigilance plan and sets out principles of good practice for the design and conduct of observational studies. The guidance is intended to aid in planning pharmacovigilance activities, especially in preparation for the early postmarketing period of a new drug.
Interagency Committee on Smoking and Health: Notice of Charter Renewal
Document Number: 05-6450
Type: Notice
Date: 2005-04-01
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Labeling Regulations
Document Number: 05-6405
Type: Notice
Date: 2005-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Medicare Program; Prospective Payment System for Inpatient Psychiatric Facilities; Final Rule; Correction
Document Number: 05-6379
Type: Rule
Date: 2005-04-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This document corrects errors that appeared in the final rule published in the Federal Register on November 15, 2004, entitled ``Medicare Program; Prospective Payment System for Inpatient Psychiatric Facilities.'' This document also supplements the November 15, 2004 final rule.
Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 05-6341
Type: Notice
Date: 2005-04-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). A notice listing all currently certified laboratories is published in the Federal Register during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at https:// workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005: Correcting Amendment
Document Number: 05-6131
Type: Rule
Date: 2005-04-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This document corrects technical errors that appeared in the final rule with comment period published in the Federal Register on November 15, 2004 entitled ``Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005.''
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.